PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

BACKGROUND: Vaginal brachytherapy is currently recommended as adjuvant treatment in patients with high-intermediate risk endometrial cancer to maximize local control and has only mild side effects and no or limited impact on quality of life. However, there is still considerable overtreatment and als...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Int J Gynecol Cancer
Main Authors: van den Heerik, Anne Sophie V M, Horeweg, Nanda, Nout, Remi A, Lutgens, Ludy C H W, van der Steen-Banasik, Elzbieta M, Westerveld, G Henrike, van den Berg, Hetty A, Slot, Annerie, Koppe, Friederike L A, Kommoss, Stefan, Mens, Jan Willem M, Nowee, Marlies E, Bijmolt, Stefan, Cibula, David, Stam, Tanja C, Jurgenliemk-Schulz, Ina M, Snyers, An, Hamann, Moritz, Zwanenburg, Aleida G, Coen, Veronique L M A, Vandecasteele, Katrien, Gillham, Charles, Chargari, Cyrus, Verhoeven-Adema, Karen W, Putter, Hein, van den Hout, Wilbert B, Wortman, Bastiaan G, Nijman, Hans W, Bosse, Tjalling, Creutzberg, Carien L
Formato: Artigo
Idioma:Inglês
Publicado em: BMJ Publishing Group 2020
Assuntos:
Clinical Trial
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7788476/
https://ncbi.nlm.nih.gov/pubmed/33046573
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/ijgc-2020-001929
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados